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Abstract
We report a patient who developed sustained hypotension during craniotomy; further, owing to a mediastinal
mass, critical tracheal stenosis and brain edema were observed after craniotomy, despite the absence of preoperative
symptomatic superior vena cava (SVC) syndrome. A 62-year-old man underwent removal of a suspected metastatic
brain tumor. The main brain tumor was speculated to be a metastatic tumor from lung cancer. A subsequent chest CT
revealed a large solid tumor in the mediastinum. The maximum reduction in the cross-sectional area of the trachea was
estimated to be 50 %. In addition, bilateral innominate veins were completely obstructed, and the superior vena cava
was involved in the mass and was completely compressed. The patient did not show any cardiopulmonary symptoms
or upper body edema. Intravenous lines were secured at the right extremity. General anesthesia was induced without
any complications and was maintained with sevoflurane, remifentanil, and rocuronium. During the surgery,
hemodynamic status fluctuated and was unstable. To maintain systolic blood pressure, continuous, massive
infusion of noradrenaline was required. After the surgery, the patient was turned to the supine position. Massive facial
edema was apparent. In addition, the bilateral upper extremities were significantly swollen. Despite the removal of the
main lesion, brain edema was still observed on head CT. Chest CT revealed that the maximum reduction in the
cross-sectional area of the trachea was estimated to be >90 %, which necessitated mechanical ventilation with
tracheal intubation. On the day following craniotomy, tracheal stenting was performed uneventfully. The patient’s
trachea was finally extubated, and his respiratory condition did not deteriorate. Although he did not develop SVC
syndrome, the patient died from asphyxiation after coughing up blood at home 5 months after the procedure. It
was suggested that fluid infusion from the upper extremities owing to the mediastinal tumor caused critical SVC
syndrome.
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Background
In case of impaired blood flow through the superior vena
cava (SVC) to the right atrium due to external compression
or intrinsic obstruction of the SVC, it is recommended that
intravenous access should be secured in the lower rather
than in the upper extremities for anesthesia management
[1, 2]. However, to the best of our knowledge, there is no
report available that describes such patients developing
SVC syndrome perioperatively. We report a patient who
developed sustained hypotension during craniotomy; fur-
ther, owing to a mediastinal mass, critical tracheal stenosis
and brain edema were observed after craniotomy, despite
the absence of preoperative symptomatic SVC syndrome.
Case presentation
A 62-year-old man was admitted to our hospital for the
removal of a suspected metastatic brain tumor. He had
suffered from gait disturbance and visual field defects
for 3 months. He has recently developed left hemiplegia
due to multiple brain lesions. He had no specific past
history aside from being a heavy smoker. The main brain
tumor was located in the right occipital lobe, and the
imaging study suggested that it was a metastatic tumor
from lung cancer. A subsequent chest CT revealed a
large solid tumor (maximum diameter, 72.25 mm) in the
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mediastinum (Fig. 1a). As for the main bronchus, the
maximum reduction in the cross-sectional area was esti-
mated to be 50 % in the side just rostral to the bifurcation
(Fig. 1b), and the length of the stenosis was approximately
35 mm. In addition, the bilateral innominate veins were
completely obstructed before merging into SVC, and SVC
was involved in the mass and was completely compressed.
Despite the imaging findings, he did not show any cardio-
pulmonary symptoms or upper body edema. Initially, we
intended to consult a pulmonologist for further examin-
ation before craniotomy; however, the removal of the
tumor was prioritized because of progressive neurological
symptoms.
Peripheral 20-G and 22-G intravenous lines were se-
cured at the right forearm and the right back of the hand.
General anesthesia was induced with 100 mg of propofol
plus 100 μg of fentanyl, and neuromuscular blockade was
achieved with 50 mg of rocuronium. Manual ventilation
with a mask was easily performed. Tracheal intubation
with a 7.5 mm silicone reinforced tracheal tube was per-
formed uneventfully. Before tube fixation, we confirmed
that the distal tube end was positioned to avoid injury to
the stenotic part of the trachea using a fiberoptic broncho-
scope. General anesthesia was maintained with 1–1.5 % of
sevoflurane, 0.05–0.1 μg/kg/min of remifentanil, and
10–15 mg/h of rocuronium. Transient hypotension was
observed during induction of the anesthesia; however, it
was treated using 8 mg of ephedrine. Craniotomy and
removal of the brain tumor was performed in the left
park-bench position. During the surgery, hemodynamic
status fluctuated and was unstable, which became par-
ticularly apparent after an increase in urine output by
mannitol administration. To maintain systolic blood pres-
sure at 80–90 mmHg through the procedures, continuous,
massive infusion of noradrenaline (0.05–0.07 μg/kg/min)
was required. The operation time for the procedures was
prolonged to 4 h and 25 min probably because of poor
brain relaxation. Fluid balance including crystalloids and
colloids infusion (5600 ml), blood products transfusion
(560 ml), urine output (2650 ml), and blood loss (625 ml)
was 2885 ml.
After the surgery, the patient was turned to the supine
position. Massive facial edema was apparent, and the bilat-
eral upper extremities were significantly swollen. Immedi-
ately, a bronchoscopic examination was performed to
evaluate the patency of the trachea, which revealed a wors-
ened stenotic lesion. Contrary to our expectation, the
respiratory condition of the patient was not impaired.
Although tracheal stenting may have been a therapeutic
option for this condition, we hesitated to select this option
because of lack of detailed information regarding the medi-
astinal tumor. After the administration of 200 mg of suga-
madex, the patient’s spontaneous breathing was sufficient;
however, he did not regain consciousness. The tracheal
tube was then removed. Critical strider accompanied with
tachycardia and hypertension was observed. It did not
seem likely that the patient’s respiratory condition would
rapidly improve. Consequently, reintubation was per-
formed to maintain patency of the trachea, which was con-
firmed by a subsequent bronchoscopic examination. The
tracheal wall was supported by the tracheal tube although
the tracheal tube did not pass the stenotic lesion. A head
and chest CT was performed before the patient was trans-
ferred to the intensive care unit (ICU). Head CT revealed
remaining brain edema with mild midline shift despite
removal of the main lesion (Fig. 2). Chest CT showed that
the maximum reduction in the cross-sectional area of the
trachea was estimated to be >90 % (Fig. 3). Compared with
Fig. 1 Contrast-enhanced CT findings. a A coronal slice showing a large mass (maximum diameter, 72.25 mm) in the mediastinum, which completely
interrupts bilateral innominate veins. b An axial slice showing that the mass compresses the trachea with significant reduction of the tracheal cross
sectional area by approximately 50 %. InV; innominate vein, IJV; internal jugular vein, BCA; brachiocephalic artery, CCA; common carotid artery, SCA;
subclavian artery, SVC; superior vena cava
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the size of the tumor before the surgery, the tumor at the
almost same CT slice level appeared to increase in size
(Fig. 1-b and Fig. 3).
After admission to ICU, the patient remained sedated
under mechanical ventilation. He was placed in the
Fowler’s position to facilitate blood flow from the upper
body. Simultaneously, diuretics (mannitol and furosemide)
were used for edema treatment. Owing to the intensive
care, the stenotic lesion improved dramatically. On the day
following craniotomy, considering the progressive nature
of the mediastinal tumor, tracheal stenting using a covered
metal stent 60 mm long (Ultraflex™, Boston Scientific
Japan, Tokyo) was performed (Fig. 4). Following the suc-
cessful tracheal stenting, the patient regained conscious-
ness immediately after cessation of sedatives. His trachea
was extubated, and his respiratory condition did not deteri-
orate. Finally, he was discharged from ICU and underwent
chemotherapy and radiotherapy. He was discharged from
the hospital 3 months after the surgery. Although the
patient did not develop SVC syndrome, he died from
asphyxiation after coughing up blood at home 2 months
after being discharged.
Discussion
SVC syndrome results from impaired blood flow through
SVC to the right atrium. Because the bilateral innominate
veins were completely obstructed and SVC was involved
in the mass and completely compressed in this case, SVC
syndrome may have occurred at any moment preopera-
tively in this patient. However, the severity of the syn-
drome depends on the rapidity of the onset of obstruction
and its location [3]. When the obstruction is slowly pro-
gressive, collateral pathways develop and symptoms are
usually mild or absent, as in this case [4]. Therefore, we
need to recognize that we underestimated his condition
because he did not show clinical symptoms and signs of
SVC syndrome.
Presuming that the respiratory and cardiovascular effects
of his mediastinal tumor were not critical in the preopera-
tive state, the reason why he developed SVC syndrome was
unclear. It was an incident that would ultimately occur.
Obviously, the primary cause of the rapid development of
SVC syndrome was fluid infusion from an upper extremity.
The fluid infusion from the upper extremity easily
exceeded the drainage capacity of the collateral pathways,
Fig. 2 Head CT after removal of the brain tumor. Significant brain
edema was confirmed in the head CT after the surgery although the
right temporooccipital tumor had been removed
Fig. 3 Chest CT after craniotomy. Chest CT showed that the maximum
reduction in the tracheal cross-sectional area was estimated to be >90 %
Fig. 4 Fiberoptic bronchoscopy during tracheal stenting. Tracheal
stenting was performed uneventfully
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which increased venous pressure and promoted upper
body edema. Simultaneously, the reduction of preload by
mannitol-induced urination and afterload by anesthesia
was not corrected by regular fluid infusion protocol using
upper extremity fluid lines, which required further fluid
infusion and administration of noradrenalin. This vicious
circle exacerbated tracheal compression by the mediastinal
tumor and brain edema. Therefore, intravenous lines in
the upper extremities are contraindicated in cases with
presence of SVC obstruction [1, 2] and such a patient can
actually develop SVC syndrome with upper extremity fluid
lines. We were overly optimistic about this case.
Conclusions
In conclusion, we presented a case of a mediastinal tumor
developing critical SVC syndrome due to fluid infusion
from the upper extremities.
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